Deakin University
Browse

The economic burden of pharmaceuticals in people diagnosed with depression, anxiety-related disorder and substance use in Australia

Download (66.98 kB)
Version 2 2024-06-02, 13:28
Version 1 2016-06-01, 15:28
conference contribution
posted on 2024-06-02, 13:28 authored by Y Lee, A Magnus, ML Chatterton, Cathy MihalopoulosCathy Mihalopoulos
The economic burden of pharmaceuticals in people diagnosed with depression, anxiety-related disorder and substance use in Australia

History

Volume

18

Pagination

A409-A410

Location

Milan, Italy

Publisher DOI

Open access

  • Yes

Link to full text

Start date

2015-11-07

End date

2015-11-11

eISSN

1524-4733

Language

eng

Notes

Article no : PMH21, Journal of Value in Health

Publication classification

E3.1 Extract of paper

Copyright notice

2015, The Authors

Title of proceedings

ISPOR 2015 : Proceedings of the Annual European Congress for the International Society for Pharmacoeconomics and Outcomes Research

Event

International Society for Pharmacoeconomics and Outcomes Research. Annual European Conference (18th : 2015 : Milan, Italy)

Issue

7

Publisher

Elsevier

Place of publication

Amsterdam, The Netherlands

Usage metrics

    Research Publications

    Categories

    Keywords

    School of Health and Social Development111714 Mental Health140208 Health Economics920410 Mental Health920207 Health Policy Economic OutcomesPopulation Health

    Licence

    All Rights Reserved

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC